Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology.

The company announced that the Canadian Intellectual Property Office has issued a Certificate of Grant of a Canadian patent No. 2,721,493.

The patent, entitled "Carbidopa/Levodopa Gastroretentive Drug Delivery," broadly covers the Accordion Pill.

It contains certain drugs including the combination of Carbidopa and Levodopa, which provides patent protection through April 2029.

The patent belongs to the Company's IN-7 patent family, which already includes patents granted in the U.S., Europe, China, Japan, South Korea, Hong Kong, South Africa, and Israel.